Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Streamlining Clinical Trials (PH117)

Streamlining Clinical Trials (PH117)

Refine processes to accelerate and improve clinical trials

Executing a successful clinical trial requires seamless communication and coordination among many stakeholders–study sponsors, contract research organizations, academic research organizations, site management organizations, patient recruiters, clinical investigators and patients.

Research shows that there is much room for improvement. The average Phase 1, 2, and 3 trials exceed their timelines by 20%. Delays in the clinical trial process cost pharma companies hundreds of thousands—even millions—in sales. Today, companies also encounter formidable challenges in the clinical development process, including the FDA’s increased involvement.

Streamlining Clinical Trials is the authoritative tool for clinical operations teams to accelerate their trials. This comprehensive guide delves into the latest industry trends and strategies for elevating efficiency. It focuses on resource allocation, performance measurement, continuous process improvement, patient and investigator recruitment and adaptive trial designs. Through extensive benchmarking data, real-company case studies and interviews with industry experts, the report shows how companies are moving their product candidates through development faster and more efficiently.

Use the report to:

* Benchmark your clinical operations against leading companies

* Clarify performance objectives

* Identify and eliminate common trial bottlenecks

* Drive successful patient recruitment campaigns

* Plan study design and protocol effectively

* Discover and apply innovative patient and investigator retention strategies

* Weigh the pros and cons of adaptive trial designs versus traditional trials

Companies Included in Report

Abbott Labs

Allergan

Amgen

AstraZeneca

Baxter Healthcare

Bristol-Myers Squibb

Covance

Cephalon

CSP

EmpiriStat

Genzyme

Gilead Sciences

GlaxoSmithKline

GlobeImmune

Hill-Rom

InNexus Biotech

Isotechnika

Medarex

Merck

Millennium Pharmaceuticals

Neurogen

Nycomed

Onyx Pharmaceuticals

Ortho-McNeil Janssen

PDL Biopharma

Pfizer

Pharma Consulting Solutions

PPD

ResearchLink

Sanofi-Aventis

Schering-Plough

Teva

UCB Pharmaceuticals

Published 2008

225 Pages

500+ Metrics

130+ Charts and Diagrams
Table of Contents
Price: $7,695.00 / €5,147.96

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions